Fate Therapeutics: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Tuesday reported a loss of $56.4 million in its fourth quarter. The San Diego-based company said it had a loss of 58 cents per share. The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research
Continue Reading